Key facts
- This page summarizes Cathy Friedman's Form 4 filing for Lyell Immunopharma, Inc. (LYEL).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 14 Dec 2021, 15:57.
Cathy Friedman - 14 Dec 2021 Form 4 Insider Report for Lyell Immunopharma, Inc. (LYEL)
- Reporting relationship
- Director
- Issuer ticker
- LYEL
- Reported as of
- 14 Dec 2021
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 14 Dec 2021, 15:57:45 UTC
- Prior SEC filing
- 23 Jun 2021
- Next SEC filing
- 25 Jan 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Heather Turner, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Cathy Friedman filed Form 4 for Lyell Immunopharma, Inc. (LYEL) on 14 Dec 2021.
Change
- Previous filing in this sequence was filed on 23 Jun 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
LYEL
transaction
Common Stock
Other
- Transaction value
- $0
- Shares
- -3,765,842
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 14 Dec 2021
- Ownership
- Lyell Investors, LLC
- Footnotes
- F1
LYEL
transaction
Common Stock
Other
- Transaction value
- $0
- Shares
- +218,722
- Change %
- +1239%
- Price
- $0.000000
- Shares after
- 236,370
- Date
- 14 Dec 2021
- Ownership
- MSL FBO J DUANE & C FRIEDMAN TTEE DUANE FAMILY TRUST
- Footnotes
- F2
LYEL
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 100,000
- Date
- 14 Dec 2021
- Ownership
- The Duane Irrevocable Trust 2020
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Pro-rata distribution by Lyell Investors, LLC to its members.
Footnote F2
Received in a pro-rata distribution from Lyell Investors, LLC. The Reporting Person is a trustee of MSL FBO J DUANE & C FRIEDMAN TTEE DUANE FAMILY TRUST ("Duane Family Trust") and therefore may be deemed to share the power to direct the disposition and vote of the shares held by the Duane Family Trust. The Reporting Person disclaims beneficial ownership of all shares held by Duane Family Trust except to any pecuniary interest therein.
Footnote F3
The Reporting Person is a trustee of The Duane Irrevocable Trust 2020 ("Duane Irrevocable Trust") and therefore may be deemed to share the power to direct the disposition and vote of the shares held by the Duane Irrevocable Trust. The Reporting Person disclaims beneficial ownership of all shares held by Duane Irrevocable Trust except to any pecuniary interest therein.